Intracellular sensing of viral DNA by the innate immune system

Microbes and Infection

Volumn 16, Issue 12, 2014, Pages 1002-1012

  Mansur, Daniel S ^a   Smith, Geoffrey L ^b   Ferguson, Brian J ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Department of Pathology ^*  (United Kingdom)

Author keywords

Autoinflammation; DNA sensing; Immune evasion; Type one interferon; Vaccines; Virus recognition

Indexed keywords

CYCLIC GMP AMP SYNTHASE; DEXD H BOX HELICASE 41; DNA DEPENDENT ACTIVATOR OF INTERFERON REGULATORY FACTOR; DNA DEPENDENT PROTEIN KINASE; DNA VACCINE; HELICASE; INTERFERON GAMMA INDUCIBLE FACTOR 16; INTERFERON REGULATORY FACTOR 3; MRE11 PROTEIN; REGULATOR PROTEIN; SYNTHETASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VACCINE;

ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DNA IMMUNIZATION; DNA VIRUS; HOST; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; INTRACELLULAR VIRAL DNA SENSING; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIRUS; VIRUS DISEASES;

MAMMALIA;

ANIMALS; AUTOIMMUNITY; DNA, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTRACELLULAR SPACE; SIGNAL TRANSDUCTION; VIRAL VACCINES; VIRUS DISEASES; VIRUSES;

EID: 84918835164     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.09.010     Document Type: Article

References (111)

1. Barrangou R., Marraffini L.A. CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell 2014, 54:234-244.
2. Labrie S.J., Samson J.E., Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol 2010, 8:317-327.
3. Rotem Z., Cox R.A., Isaacs A. Inhibition of virus multiplication by foreign nucleic acid. Nature 1963, 197:564-566.
4. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54(Pt 1):1-13.
5. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
6. Blatt N.B., Glick G.D. Anti-DNA autoantibodies and systemic lupus erythematosus. Pharmacol Ther 1999, 83:125-139.
7. Menezes G.B., Mansur D.S., McDonald B., Kubes P., Teixeira M.M. Sensing sterile injury: opportunities for pharmacological control. Pharmacol Ther 2011, 132:204-214.
8. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
9. Barton G.M., Kagan J.C., Medzhitov R. Intracellular localization of toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006, 7:49-56.
10. Stetson D.B., Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24:93-103.
11. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., et al. A toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006, 7:40-48.
12. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
13. Bauernfeind F., Hornung V. Of inflammasomes and pathogens-sensing of microbes by the inflammasome. EMBO Mol Med 2013, 5:814-826.
14. Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A., Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 2009, 10:1065-1072.
15. Ablasser A., Goldeck M., Cavlar T., Deimling T., Witte G., Rohl I., et al. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 2013, 498:380-384.
16. Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
17. Ferguson B.J., Mansur D.S., Peters N.E., Ren H., Smith G.L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 2012, 1:e00047.
18. Kondo T., Kobayashi J., Saitoh T., Maruyama K., Ishii K.J., Barber G.N., et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci U S A 2013, 110:2969-2974.
19. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
20. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
21. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
22. Wu J., Sun L., Chen X., Du F., Shi H., Chen C., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339:826-830.
23. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol 2011, 12:959-965.
24. Li X.D., Wu J., Gao D., Wang H., Sun L., Chen Z.J. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 2013, 341:1390-1394.
25. Fernandes-Alnemri T., Yu J.W., Juliana C., Solorzano L., Kang S., Wu J., et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010, 11:385-393.
26. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010, 11:395-402.
27. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
28. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
29. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035-1040.
30. Mansur D.S., Kroon E.G., Nogueira M.L., Arantes R.M., Rodrigues S.C., Akira S., et al. Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol 2005, 166:1419-1426.
31. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004, 103:1433-1437.
32. Lima G.K., Zolini G.P., Mansur D.S., Freire Lima B.H., Wischhoff U., Astigarraga R.G., et al. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am J Pathol 2010, 177:2433-2445.
33. Dai P., Cao H., Merghoub T., Avogadri F., Wang W., Parikh T., et al. Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway. J Virol 2011, 85:10814-10825.
34. Dai P., Wang W., Cao H., Avogadri F., Dai L., Drexler I., et al. Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway. PLoS Pathog 2014, 10:e1003989.
35. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003, 4:491-496.
36. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 2004, 101:233-238.
37. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
38. Iwamura T., Yoneyama M., Yamaguchi K., Suhara W., Mori W., Shiota K., et al. Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 2001, 6:375-388.
39. Tamura T., Yanai H., Savitsky D., Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008, 26:535-584.
40. Ishii K.J., Kawagoe T., Koyama S., Matsui K., Kumar H., Kawai T., et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 2008, 451:725-729.
41. Shu C., Sankaran B., Chaton C.T., Herr A.B., Mishra A., Peng J., et al. Structural insights into the functions of TBK1 in innate antimicrobial immunity. Structure 2013, 21:1137-1148.
42. Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
43. Gao P., Ascano M., Zillinger T., Wang W., Dai P., Serganov A.A., et al. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell 2013, 154:748-762.
44. Tanaka Y., Chen Z.J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci Signal 2012, 5:ra20.
45. Pham T.H., Kwon K.M., Kim Y.E., Kim K.K., Ahn J.H. DNA sensing-independent inhibition of herpes simplex virus 1 replication by DAI/ZBP1. J Virol 2013, 87:3076-3086.
46. Sharma S., DeOliveira R.B., Kalantari P., Parroche P., Goutagny N., Jiang Z., et al. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 2011, 35:194-207.
47. Lippmann J., Rothenburg S., Deigendesch N., Eitel J., Meixenberger K., van Laak V., et al. IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell Microbiol 2008, 10:2579-2588.
48. Rebsamen M., Heinz L.X., Meylan E., Michallet M.C., Schroder K., Hofmann K., et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 2009, 10:916-922.
49. Upton J.W., Kaiser W.J., Mocarski E.S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012, 11:290-297.
50. Caposio P., Gugliesi F., Zannetti C., Sponza S., Mondini M., Medico E., et al. A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem 2007, 282:33515-33529.
51. Kerur N., Veettil M.V., Sharma-Walia N., Bottero V., Sadagopan S., Otageri P., et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 2011, 9:363-375.
52. Monroe K.M., Yang Z., Johnson J.R., Geng X., Doitsh G., Krogan N.J., et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2013, 343:428-432.
53. Cooper A., Garcia M., Petrovas C., Yamamoto T., Koup R.A., Nabel G.J. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 2013, 498:376-379.
54. Parvatiyar K., Zhang Z., Teles R.M., Ouyang S., Jiang Y., Iyer S.S., et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol 2012, 13:1155-1161.
55. Blunt T., Finnie N.J., Taccioli G.E., Smith G.C., Demengeot J., Gottlieb T.M., et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995, 80:813-823.
56. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 2010, 79:181-211.
57. Karpova A.Y., Trost M., Murray J.M., Cantley L.C., Howley P.M. Interferon regulatory factor-3 is an invivo target of DNA-PK. Proc Natl Acad Sci U S A 2002, 99:2818-2823.
58. Zhang X., Brann T.W., Zhou M., Yang J., Oguariri R.M., Lidie K.B., et al. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol 2011, 186:4541-4545.
59. Moll U., Lau R., Sypes M.A., Gupta M.M., Anderson C.W. DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene 1999, 18:3114-3126.
60. Burdette D.L., Monroe K.M., Sotelo-Troha K., Iwig J.S., Eckert B., Hyodo M., et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011, 478:515-518.
61. Gao P., Ascano M., Wu Y., Barchet W., Gaffney B.L., Zillinger T., et al. Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 2013, 153:1094-1107.
62. Zhang X., Shi H., Wu J., Zhang X., Sun L., Chen C., et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell 2013, 51:226-235.
63. Diner E.J., Burdette D.L., Wilson S.C., Monroe K.M., Kellenberger C.A., Hyodo M., et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep 2013, 3:1355-1361.
64. Kuchta K., Knizewski L., Wyrwicz L.S., Rychlewski L., Ginalski K. Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human. Nucleic Acids Res 2009, 37:7701-7714.
65. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
66. Zhang X., Wu J., Du F., Xu H., Sun L., Chen Z., et al. The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop. Cell Rep 2014, 6:421-430.
67. Civril F., Deimling T., de Oliveira Mann C.C., Ablasser A., Moldt M., Witte G., et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 2013, 498:332-337.
68. Ablasser A., Schmid-Burgk J.L., Hemmerling I., Horvath G.L., Schmidt T., Latz E., et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 2013, 503:530-534.
69. Gao D., Wu J., Wu Y.T., Du F., Aroh C., Yan N., et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013, 341:903-906.
70. Schoggins J.W., MacDuff D.A., Imanaka N., Gainey M.D., Shrestha B., Eitson J.L., et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 2013, 505:691-695.
71. Diebold S.S., Montoya M., Unger H., Alexopoulou L., Roy P., Haswell L.E., et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 2003, 424:324-328.
72. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89:1-47.
73. Andrejeva J., Childs K.S., Young D.F., Carlos T.S., Stock N., Goodbourn S., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U S A 2004, 101:17264-17269.
74. Smith G.L., Benfield C.T., Maluquer de Motes C., Mazzon M., Ember S.W., Ferguson B.J., et al. Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 2013, 94:2367-2392.
75. Fahy A.S., Clark R.H., Glyde E.F., Smith G.L. Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol 2008, 89:2377-2387.
76. Peters N.E., Ferguson B.J., Mazzon M., Fahy A.S., Krysztofinska E., Arribas-Bosacoma R., et al. A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog 2013, 9:e1003649.
77. Aglipay J.A., Lee S.W., Okada S., Fujiuchi N., Ohtsuka T., Kwak J.C., et al. A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 2003, 22:8931-8938.
78. Cristea I.M., Moorman N.J., Terhune S.S., Cuevas C.D., O'Keefe E.S., Rout M.P., et al. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol 2010, 84:7803-7814.
79. Li T., Chen J., Cristea I.M. Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion. Cell Host Microbe 2013, 14:591-599.
80. Li T., Diner B.A., Chen J., Cristea I.M. Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci U S A 2012, 109:10558-10563.
81. Gariano G.R., Dell'Oste V., Bronzini M., Gatti D., Luganini A., De Andrea M., et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog 2012, 8:e1002498.
82. Orzalli M.H., DeLuca N.A., Knipe D.M. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A 2012, 109:E3008-E3017.
83. Ablasser A., Hertrich C., Wassermann R., Hornung V. Nucleic acid driven sterile inflammation. Clin Immunol 2013, 147:207-215.
84. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
85. Yoshida H., Okabe Y., Kawane K., Fukuyama H., Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 2005, 6:49-56.
86. Ahn J., Gutman D., Saijo S., Barber G.N. STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A 2012, 109:19386-19391.
87. Gall A., Treuting P., Elkon K.B., Loo Y.M., Gale M., Barber G.N., et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36:120-131.
88. Ablasser A., Hemmerling I., Schmid-Burgk J.L., Behrendt R., Roers A., Hornung V. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 2014.
89. Aicardi J., Goutieres F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984, 15:49-54.
90. Behrendt R., Roers A. Mouse models for Aicardi-Goutieres syndrome provide clues to the molecular pathogenesis of systemic autoimmunity. Clin Exp Immunol 2014, 175:9-16.
91. Rice G.I., Forte G.M., Szynkiewicz M., Chase D.S., Aeby A., Abdel-Hamid M.S., et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 2013, 12:1159-1169.
92. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., Ali M., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006, 38:917-920.
93. Brinkmann V., Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol 2007, 5:577-582.
94. Hakkim A., Furnrohr B.G., Amann K., Laube B., Abed U.A., Brinkmann V., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A 2010, 107:9813-9818.
95. Villanueva E., Yalavarthi S., Berthier C.C., Hodgin J.B., Khandpur R., Lin A.M., et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011, 187:538-552.
96. Tojo T., Kaburaki J., Hayakawa M., Okamoto T., Tomii M., Homma M. Precipitating antibody to a soluble nuclear antigen "Ki" with specificity for systemic lupus erythematosus. Ryumachi 1981, 21(Suppl.):129-140.
97. Schild-Poulter C., Su A., Shih A., Kelly O.P., Fritzler M.J., Goldstein R., et al. Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases. Rheumatology 2008, 47:165-171.
98. Caneparo V., Cena T., De Andrea M., Dell'oste V., Stratta P., Quaglia M., et al. Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Lupus 2013, 22:607-613.
99. Cavazzana I., Ceribelli A., Airo P., Zingarelli S., Tincani A., Franceschini F. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun Rev 2009, 8:580-584.
100. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005, 115:407-417.
101. Brill A., Fuchs T.A., Savchenko A.S., Thomas G.M., Martinod K., De Meyer S.F., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012, 10:136-144.
102. Oka T., Hikoso S., Yamaguchi O., Taneike M., Takeda T., Tamai T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 485:251-255.
103. Diana J., Simoni Y., Furio L., Beaudoin L., Agerberth B., Barrat F., et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med 2013, 19:65-73.
104. Coffman R.L., Sher A., Seder R.A. Vaccine adjuvants: putting innate immunity to work. Immunity 2010, 33:492-503.
105. Desmet C.J., Ishii K.J. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol 2012, 12:479-491.
106. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011, 12:509-517.
107. Liu M.A. Immunologic basis of vaccine vectors. Immunity 2010, 33:504-515.
108. Gonzalez-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012, 12:125-135.
109. Delaloye J., Roger T., Steiner-Tardivel Q.G., Le Roy D., Knaup Reymond M., Akira S., et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 2009, 5:e1000480.
110. Sumner R.P., Ren H., Smith G.L. Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol 2013, 94:1121-1126.
111. Unterholzner L., Sumner R.P., Baran M., Ren H., Mansur D.S., Bourke N.M., et al. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 2011, 7:e1002247.